The President, Professor A. L. Latner, took the chair and opened the meeting with a brief introduction of the speakers.
Dr. J. Axelrod (National Institutes of Health, Bethesda, U.S.A.) opened the Symposium with a masterly exposition of the Metabolism of Adrenaline and Noradrenaline. He outlined the pathways of the formation of these substances and described some of the advances of knowledge which have recently been made, many of which he and his colleagues have accomplished.
Dr. B. A. Callingham (London University) discussed the Determination of Catecholamines in Biological Materials, considering mainly the assay of adrenaline, noradrenaline and dopamine. He gave a brief description of some of the more commonly used biological preparations, the rat blood pressure and rabbit aorta as screening tests for urine and Vogt's method for blood plasma, noting the limitations of these methods, particularly for the differential estimation of the catecholamines.
Turning to the chemical methods, he dealt firstly with extraction procedures using dilute acids, acid saturated ethanol and organic solvents and then with purification procedures, the primary step to remove large quantities of unwanted material, followed by the secondary step to separate the amines from each other.
Dr. Callingham then discussed the methods of estimation.
He described the colorimetric methods, although widely used, as non-specific and relatively insensitive. The only method of this sort that was reliable was the paper chromatographic technique.
Of the fluorescence methods, probably the most suitable available, there were two basic methods, the Trihydroxyindole method and the Ethylenediamine method, which he considered to be very sensitive and, with care, very specific. Dr. Callingham concluded with a description of a modified trihydroxyindole method for dopamine which would produce a derivative easily distinguishable from the fluorescent lutines of adrenaline and noradrenaline.
Dr. P. Smith (R.A.F. Institute of Aviation Medicine, Farnborough) dealt with the" Determination of Metabolites of Catecholamines " by chromatographic methods. He gave methods for the concentration of the phenolic acids in urine by solvent extraction and claimed that chromatography of the extracts was comparatively simple and suitable for the detection of HMMA, homovanillic acid and other compounds of interest. The procedures for the chromatography of the phenolic amines were, however, more tedious but the information gained justified the effort; thus the separation of metadrenaline from normetadrenaline permitted conclusions concerning the individual secretion rates of the parent amines. Dr. Smith concluded his paper with a description of the factors governing successful chromatography and gave many examples of typical results.
Dr. C. R. Ruthven (Queen Charlottes' Maternity Hospital, London) read a paper on the "Determination of Metabolites of Catecholaminesby Other Techniques". He critically reviewed the published methods, except paper chromatographic methods, for the determination of the metabolites. The procedures were shown to fall into four groups, colorimetry after azo-dye formation, paper electrophoresis, fluorimetry and spectrophotimetry after conversion to vanillin. The techniques in each group were examined and their merits and limitations assessed. Selected methods for the determination of homovanillic acid, metadrenalines and 4-hydroxy-3-methoxymandelic acid were given in detail as well as some guidance on the choice of procedure most suited to clinical laboratory practice.
The "Clinical and Pathological Aspects of Phaeochromocytoma " were discussed in detail by Dr. R. Winston Evans (David Lewis Northern Hospital, Liverpool).
Dr. R. Robinson (Group Laboratory, Warwick) then read a paper on the "Clinical Chemistry of Phaeochromocytomas ". He said that earlier workers have shown that the urine and peripheral blood of phaeochromocytoma patients contained increased concentrations of adrenaline and noradrenaline. They also showed that the ratio of one amine to the other varies widely both in the body fluids and in the tumours themselves.
The investigations of him and his colleagues suggested that the composition of the secretions discharged by phaeochromocytomas was more complex than was generally realized. Using chromatographic techniques, they had detected the 3-0-methyl derivatives of the following catecholamines in the urines of phaeochromocytoma patients: adrenaline, noradrenaline, Nmethyl adrenaline, N-isopropyl noradrenaline and 3-hydroxytyramine.
A patient with a malignant phaeochromocytoma excreted particularly large amounts of 3-methoxytyramine and homovanillic acid, both metabolites of 3-hydroxytyramine.
A study of twenty-five patients with phaeochromocytoma showed that the Hingerty (1957) test was valuable.
However, two patients excreted less than 180 fLg a day of total catecholamines-the upper limit of normality set by Hingerty. They recommended lowering this limit to 100 ug a day.
The following scheme was suggested for the detection of phaeochromocytomas :
I. Carry out at least two Hingerty tests. Reject all specimens containing less than 100 fLg oftotal catecholamines a day. This will eliminate about 95 % of the specimens submitted.
2. Measure the metadrenalines by Pisano's method (1960) . An excretion of more than 2 mgm. a day is good evidence of a phaechromocytoma.
3. Submit all specimens with a high concentration of total metadrenalines to a laboratory carrying out phenolic acid and amine chromatography. Examine the urine particularly for 3-methoxytyramine and homovanillic acid since there is good evidence that the excretion of these compounds is abnormally high in patients with malignant phaeochromocytomas. Finally, it was emphasized that twenty-five cases of phaeochromocytoma was a large collection only because the tumour is so rare. It is too small an amount of material from which to draw inflexible conclusions.
Though all of their cases would have been detected by the scheme outlined above, further experience may show it to be inadequate.
Dr. H. B. Marsden (Royal Manchester
Children's Hospital, Pendlebury) discussed the .. Pathological Aspects of Neuroblastoma ".
The" Clinical Chemistry of Neuroblastomas " was the subject of Mr. Bell's paper (The Royal Infirmary, Manchester). He gave a brief review of the literature illustrating the variety of catecholamines and their metabolites which have been detected in the urine of patient's suffering from neuroblastoma.
These include noradrenaline, 3-hydroxytyramine (dopamine), 3-methoxytyramine, normetadrenaline, 4-hydroxy-3-methoxy mandelic acid (HMMA) and homovanillic acid with isolated reports of 4-hydroxy-3-methoxy phenylalanine.
The variations encountered were illustrated by the results obtained for urine specimens from sixteen cases of neuroblastoma investigated during the past two years where total catecholamines, normetadrenaline and HMMA have been determined and phenolic acid chromatograms obtained. Following the work ofVoorhess and Gardner (1962) the cases were grouped according to their urinary excretion pattern. In group I (general increase in all metabolites) there were ten cases of which four showed a greater relative increase of HMMA, three of normetadrenaline and three of total catecholamines (mainly hydroxytyramine). Group 2 (with cases showing a very marked increase of total catecholamines but relatively little increase of normetadrenaline and HMMA) contained three cases. This group was also characterized by the presence of atypical material on the phenolic acid chromatograms. Group 3 (only slight increase of total catecholamines but definite increase of normetadrenaline and HMMA) contained three cases. Reference was made to a fourth group with negative chemical findings but in view of the difference of opinion between clinical and histological diagnosis in these cases, it was suggested that they required further investigation.
The response to treatment (radiation therapy and/or surgery) was illustrated by reference to four cases, representing each of the three main groups given above, which were followed for varying periods up to one year. As a result of these findings it was tentatively suggested that cases in Group 1 mayor may not be treatable, those in Group 2 were probably untreatable and those in Group 3 had the best prognosis of all.
Finally, methods were discussed for the routine screening of urine specimens for the presence of excess catecholamines and their metabolites, with particular reference to neuroblastoma. A combination of two methods was suggested (Gitlow et al. (1960) for HMMA and Bell et al. (1958) for total catecholamines) and it was shown how the cases could be classified. Group 1 both tests positive, Group 2 total catecholamines positive, HMMA negative, and Group 3 total catecholamines weakly positive, HMMA positive.
The second part of the Symposium was devoted to consideration of the hydroxyindoles. It was opened by Dr. J. B. Jepson (Courtauld Institute of Biochemistry, London) with a paper "Metabolism of the Hydroxyindoles". He presented, with deceptive ease, the pathways of metabolism of not only the 5-hydroxyindoles but also of other hydroxyindoles as well and, while discussing the significance of the former, suggested that the latter may well be found to be abnormal, and significantly so in some disease states.
Dr. M. Sandler (Queen Charlotte's Maternity Hospital, London) dealt with the " Determination of Hydroxyindoles in Biological Materials". He gave a summary of the biological procedures available for the assay of the 5-hydroxytryptamine and a detailed critique for the measurement of the various hydroxylated indole derivatives. Dr. P. J. D. Snow (Bolton Hospital Group) read a paper on the "Clinical Aspects of Carcinoid Tumours". He said that carcinoid tumours are comparatively rare tumours of low malignancy, most commonly arising from the lower part of the small intestine.
They rarely produce any specific local effects but because they liberate 5-hydroxytryptamine and, possibly, other biologically active substances, they may cause a number of systemic effects when metastases are present. These effects include flushing, diarrhoea, asthma and valvular lesions of the heart. The effects were discussed in detail.
Some tumours liberate 5-hydroxytryptophan rather than 5-hydroxytryptamine and present a rather different clinical and pathological picture. Treatment with 5-hydroxytryptamine antagonists, or alpha-methyl dopa to block the formation of this substance are only effective against certain of the systemic effects.
Professor A. C. P. Campbell (University of Manchester) discussed the pathological aspects in a paper entitled "Pathological Aspects of Carcinoid Tumours". Dr. A. H. Gowenlock (University of Manchester) concluded this part of the Symposium with a paper on the "Clinical Chemistry of Carcinoid Tumours".
His paper dealt mainly with the levels of 5-hydroxytryptophan (5-HTP), 5-hydroxytryptamine (5-HT) and 5-hydroxyindole-3-acetic acid (5-HIAA) in the tissues, blood and urine of man. Normal levels for these substances were reviewed and the absence of 5-HTP from all sites noted. The major metabolite of the 5-hydroxyindoles is 5-HIAA, found in the urine. Dietary factors may influence the output.
The data from 104 cases of intestinal carcinoid were reviewed. Urinary 5-HIAA levels showed a great variation.
High levels are usually associated with the presence of hepatic metastases and of the carcinoid syndrome but this was not universally so. Blood and urinary 5-HT levels showed similar relationships but they were rarely abnormal unless urinary 5-HIAA was increased. This was the most sensitive test for the presence of a carcinoid tumour, although tumours which had not metastasized may be associated with a normal output of 5-HIAA.
The factors influencing tissue 5-HT levels in carcinoid tumours were then discussed. Tissue levels were usually elevated, often markedly so. This was to be expected as such tumours contain many argentiffin-positive cells rich in 5-HT. Tissue levels may afford biochemical confirmation of the histological diagnosis especially in cases where the tumour is localized and urinary 5-HlAA is not increased.
The data from twenty-nine cases of bronchial carcinoid were analysed. These tumours were capable of secreting 5-HT and may produce a typical carcinoid syndrome. On the whole, urinary 5-HIAA levels were lower than with intestinal tumours and tissue levels of 5-HT much lower, corresponding to the altered histochemical reactions in most bronchial carcinoids. The tumours were usually argentiffin-negative but argyrophil-positive.
Finally, data from a group of cases of atypical carcinoid tumour were considered. The natural isotope 127 1 is utilized by man in such small amounts (150 !Jog/daily) that its chemical measurement is both arduous and prone to error. The introduction of the radioisotope 131 1 (half-life 8 days) enabled great advances in both diagnosis and therapy, and over fifteen years no carcinogenic risk has emerged from its widespread usage. However, recent biopsies of glands exposed to 131 1 many years previously have revealed unhealthy epithelial proliferation (Sheline et 01., 1962) . The radiosotope 132 1 (half-life 2·3 hours) is now readily available and offers the following advantages :
(i) The radiation exposure is about I/lOOth The Measurement of Normal Thyroid Activity of that with similar use of 131 1 (Einhorn, Balance studies (Dougherty et al., 1951) in the 1958).
rat have shown that the thyroidal iodine is main-(ii) Repeated tests, with insignificant back-tained in a steady state, the rate of hormone ground error, have enabled the definition secretion being constant over many days and in of the limits of individual variation, and equilibrium with iodine uptake. Thus small have improved the accuracy of tri-diurnal variations of the ten minute 132 1 uptake iodothyronine (T3) suppression and recorded in man (Einhorn, 1958) probably result thyrotrophin (TSH) tests. from varying dilutions of the radioisotope within
